INFECTIOUS DISEASES IN CLINICAL PRACTICE

Scope & Guideline

Advancing knowledge in infectious disease management.

Introduction

Welcome to your portal for understanding INFECTIOUS DISEASES IN CLINICAL PRACTICE, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1056-9103
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1992 to 2002, from 2004 to 2024
AbbreviationINFECT DIS CLIN PRAC / Infect. Dis. Clin. Pract.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Infectious Diseases in Clinical Practice' focuses on the evolving landscape of infectious diseases, emphasizing clinical research, case studies, and advancements in diagnostic and therapeutic practices.
  1. Clinical Management of Infectious Diseases:
    The journal emphasizes the clinical aspects of infectious diseases, including case reports and management strategies tailored to specific patient populations.
  2. Antimicrobial Stewardship:
    There is a consistent focus on antimicrobial stewardship, highlighting the need for responsible antibiotic use and strategies to combat antimicrobial resistance.
  3. Emerging Infections and Public Health:
    The journal addresses emerging infectious diseases and their public health implications, particularly in the context of ongoing global health challenges like the COVID-19 pandemic.
  4. Diagnostic Innovations:
    Research on new diagnostic methods and technologies for infectious diseases is a core area, showcasing advancements that enhance detection and treatment efficacy.
  5. Zoonotic and Vector-Borne Diseases:
    Special attention is given to zoonotic diseases and those transmitted by vectors, reflecting the journal's commitment to understanding the complex interplay between humans, animals, and pathogens.
The journal reflects a dynamic landscape of research, with several emerging themes that are increasingly relevant to current clinical practice and public health.
  1. Impact of COVID-19 on Infectious Disease Management:
    Research related to the COVID-19 pandemic continues to dominate publications, exploring its effects on patient management, hospital protocols, and the emergence of new infectious threats.
  2. Opportunistic Infections in Immunocompromised Patients:
    There is an increasing focus on opportunistic infections, particularly in patients with compromised immune systems, highlighting the need for tailored management strategies.
  3. Antimicrobial Resistance and Novel Therapeutics:
    The urgency of addressing antimicrobial resistance is evident, with a surge in studies exploring novel therapeutic options and resistance mechanisms.
  4. Telemedicine and Digital Health in Infectious Diseases:
    The integration of telemedicine into infectious disease care has gained prominence, reflecting changes in healthcare delivery models and patient engagement during the pandemic.
  5. Public Health and Zoonotic Disease Surveillance:
    Emerging research on zoonotic diseases and their surveillance is gaining traction, emphasizing the importance of a One Health approach in managing infectious diseases.

Declining or Waning

While some themes remain prominent, others appear to be waning in focus within the journal, indicating shifts in research priorities and clinical relevance.
  1. Traditional Infectious Disease Models:
    There is a noticeable decline in papers focusing solely on traditional infectious disease models, as the journal shifts towards more contemporary issues like pandemics and emerging pathogens.
  2. Single Pathogen Focus Studies:
    Research concentrating on single pathogens without considering broader epidemiological contexts is becoming less common, with a trend towards studies that incorporate multifactorial analyses.
  3. Historical Perspectives:
    Papers that delve into historical perspectives on infectious diseases are less frequent, with a shift towards immediate clinical implications and current challenges.
  4. Basic Science of Infectious Agents:
    Research focusing exclusively on the basic microbiology of infectious agents without direct clinical application is declining, as the emphasis moves towards translational research.
  5. Non-Communicable Disease Interactions:
    The intersection of infectious diseases with non-communicable diseases, while still relevant, is less emphasized as the journal concentrates more on acute infectious disease challenges.

Similar Journals

Flora Infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Dergisi

Unveiling breakthroughs in microbiological practices for a healthier future.
Publisher: BILIMSEL TIP YAYINEVIISSN: 1300-932XFrequency: 4 issues/year

Flora Infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Dergisi, published by BILIMSEL TIP YAYINEVI, is a leading journal dedicated to the field of infection diseases and clinical microbiology. With an ISSN of 1300-932X and an E-ISSN of 2602-2842, this journal has been an established Open Access platform since 1999, allowing researchers worldwide to access critical studies and advancements without barriers. The journal aims to disseminate high-quality research articles, reviews, and case studies that address emerging challenges in infection management and microbiological practices. By fostering a collaborative environment for professionals, researchers, and students alike, Flora Infeksiyon Hastaliklari ve Klinik Mikrobiyoloji Dergisi plays a vital role in advancing knowledge and practices within the microbiological and clinical spheres. Its commitment to open access ensures that invaluable resources are widely available, supporting the growth and development of innovation in the medical field.

Tropical Medicine and Infectious Disease

Bridging science and care for infectious diseases.
Publisher: MDPIISSN: Frequency: 12 issues/year

Tropical Medicine and Infectious Disease, published by MDPI, is a leading peer-reviewed journal dedicated to advancing the field of tropical medicine and infectious diseases. With an open access model established since 2016, this journal fosters a collaborative environment for researchers, professionals, and students from around the world to disseminate cutting-edge findings and innovative approaches to public health challenges, particularly in tropical regions. The journal has earned recognition, achieving a Q2 quartile ranking in notable fields including Immunology and Microbiology, Infectious Diseases, and Public Health, Environmental, and Occupational Health in 2023, indicative of its influence and relevance in the scientific community. With a focus on high-quality research, Tropical Medicine and Infectious Disease aims to bridge the gap between basic science and clinical application, providing invaluable insights critical for combating infectious diseases and improving health outcomes in vulnerable populations. The journal’s accessibility and substantial indexing in major databases further solidify its importance as a key platform for impactful research in this essential field.

LANCET INFECTIOUS DISEASES

Connecting Researchers to Combat Global Health Threats
Publisher: ELSEVIER SCI LTDISSN: 1473-3099Frequency: 12 issues/year

LANCET INFECTIOUS DISEASES is a premier journal published by Elsevier Science Ltd, dedicated to disseminating high-quality research and comprehensive reviews in the field of infectious diseases. Since its inception in 2001, the journal has become a pivotal resource in the medical community, recognized for its rigorous peer-review process and impactful contributions to public health. With an impressive Scopus rank of #2 out of 344 in the category of Medicine - Infectious Diseases, it consistently ranks in the 99th percentile, highlighting its importance and influence in shaping clinical and epidemiological research. The journal's commitment to advancing knowledge in infectious diseases is underscored by its Q1 quartile designation in 2023, affirming its status as a leading academic outlet. Although not an open-access journal, LANCET INFECTIOUS DISEASES provides essential insights for researchers, healthcare professionals, and students, bridging the gap between cutting-edge research and practical application in an increasingly interconnected world.

Archives of Clinical Infectious Diseases

Connecting Science and Practice in Infectious Diseases
Publisher: BRIEFLANDISSN: 2345-2641Frequency: 4 issues/year

Archives of Clinical Infectious Diseases is a peer-reviewed journal dedicated to advancing knowledge in the field of infectious diseases, published by BRIEFLAND in Iran. With a broad scope, it covers various aspects of cardiology, critical care, immunology, microbiology, public health, and toxicology, affirming its relevance in today's health landscape. Despite the lack of open access options, the journal maintains a strong reputation, reflected in its Q3 ranking in multiple categories within the 2023 category quartiles. The journal aims to provide a platform for researchers and practitioners to disseminate critical findings that can impact clinical practices and public health policies. Its commitment to rigorous peer review ensures that only high-quality research is published, thereby serving as an essential resource for professionals, students, and public health advocates. For those engaged in the ever-evolving world of infectious diseases, Archives of Clinical Infectious Diseases stands as a vital contribution to the medical literature.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA

Bridging the gap between research and real-world clinical practices.
Publisher: EDICIONES DOYMA S AISSN: 0213-005XFrequency: 10 issues/year

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA is a prominent journal dedicated to the fields of infectious diseases and clinical microbiology, published by EDICIONES DOYMA S A in Spain. With an ISSN of 0213-005X and an e-ISSN of 1578-1852, the journal has been a cornerstone of research and scholarly communication since its inception in 1989. As of 2023, it holds a Q3 category ranking in Infectious Diseases, highlighting its significance in the field, alongside a Q4 ranking in the related area of Microbiology. Although the journal is not open access, it remains an essential resource for professionals, researchers, and students aiming to stay informed on advancements and studies that impact clinical practices in infectious diseases. With Scopus ranks indicating a percentile ranking in the 20th to 34th range across various sub-disciplines, ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA continually contributes to the dialogue and development of science, fostering a deeper understanding of complex microbial interactions and disease mechanisms.

Kleintierpraxis

Empowering practitioners with cutting-edge research.
Publisher: M H SCHAPER GMBH CO KGISSN: 0023-2076Frequency: 12 issues/year

Kleintierpraxis is a prominent journal dedicated to the field of small animal veterinary science, published by M H SCHAPER GMBH CO KG in Germany. With an ISSN of 0023-2076, the journal aims to disseminate cutting-edge research, clinical findings, and advancements in veterinary practices affecting small animals. Although it is categorized within the Q4 quartile for Small Animals in 2023 and holds a Scopus rank of 20 out of 20, its role in providing valuable insights to practitioners, researchers, and students in veterinary medicine cannot be underestimated. The journal covers a wide range of topics pertinent to veterinary care, diagnostics, and treatment methodologies, offering an essential resource for understanding the complexities of small animal health. While currently not open access, Kleintierpraxis continues to be a vital contribution to the veterinary literature landscape from 1996 through 2024, fostering professional development and knowledge within the community.

Annals of Clinical Microbiology and Antimicrobials

Connecting researchers to the latest advancements in infectious diseases.
Publisher: BMCISSN: Frequency: 1 issue/year

Annals of Clinical Microbiology and Antimicrobials, published by BMC, is a leading open-access journal that has been fostering scientific discourse in the fields of microbiology and infectious diseases since its inception in 2002. With an established reputation for excellence, this journal is positioned in the prestigious Q1 category across multiple disciplines, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology as of 2023. This journal serves as a vital platform for researchers, healthcare professionals, and students, promoting the latest advancements in clinical microbiology and antimicrobial research. Access to its invaluable content is open to all, reflecting the commitment to disseminate knowledge universally. The Annals of Clinical Microbiology and Antimicrobials is based in the United Kingdom and continues to pave the way for innovation and discussions that shape the future of clinical practices in microbiology.

CLINICAL MICROBIOLOGY AND INFECTION

Unveiling Insights for a Healthier Tomorrow
Publisher: ELSEVIER SCI LTDISSN: 1198-743XFrequency: 12 issues/year

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.

International Journal of Antimicrobial Agents

Pioneering Insights into Antimicrobial Efficacy and Safety
Publisher: ELSEVIERISSN: 0924-8579Frequency: 12 issues/year

International Journal of Antimicrobial Agents, published by Elsevier, stands as a premier platform in the fields of Infectious Diseases, Microbiology, and Medical Pharmacology. With an impressive impact factor and ranked in the Q1 category across multiple medical disciplines in 2023, this journal is recognized for its contribution to advancing knowledge and understanding in the efficacy and safety of antimicrobial treatments. Its comprehensive scope from 1991 to 2024 allows for the publishing of original research, reviews, and commentary on pressing issues related to antimicrobial resistance, treatment strategies, and pharmacological innovations. With a strong emphasis on high-quality research as reflected in its Scopus rankings, the journal is an essential resource for researchers, clinicians, and students dedicated to improving patient outcomes in the face of evolving microbiological challenges. Engage with the latest findings and methodologies through this vital academic resource, available in print and online, from the heart of the Netherlands.

Open Forum Infectious Diseases

Empowering global health through accessible science.
Publisher: OXFORD UNIV PRESS INCISSN: 2328-8957Frequency: 12 issues/year

Open Forum Infectious Diseases (ISSN: 2328-8957; E-ISSN: 2328-8957) is a leading open-access journal published by Oxford University Press, dedicated to advancing the field of infectious diseases. Since its inception in 2014, the journal has provided a platform for researchers to disseminate impactful findings in a rapidly evolving domain, achieving a remarkable Q1 ranking in both the Infectious Diseases and Oncology categories as of 2023. The journal encourages rigorous and innovative research, contributing significantly to global health discussions and informing best practices in clinical settings. As an open-access journal, it ensures that its content is accessible to a wide audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. Positioned in the heart of the United States, Open Forum Infectious Diseases serves as a critical resource for the academic community, and its continued commitment to quality and relevance secures its status as an essential publication in the field.